| NCT ID | NCT05221554 |
| Status | Recruiting |
| Phase | — |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Condition | Total Hip Arthroplasty |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2022-08-01 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Replacing diseased hip joints with prosthetic implants in a procedure called total hip arthroplasty (THA) is associated with high rates of patient satisfaction, pain relief, and functional improvement when the implant is appropriately placed. Incorrect implant size or placement may lead to a breadth of negative outcomes, which could result in the need for implant revision. It is difficult to assess the precise orientation of patient hips on the operating table, with one study revealing that only 26% of acetabular cups placed without technological assistance are correctly positioned. Using computer navigation as a guide to achieve optimal implant alignment may improve successful placement rates. The additional incorporation of real-time modeling software may further help realize higher rates of successful implant placement. This study, therefore, aims to investigate a computer navigation system coupled with real-time modeling software to establish the benefit of such technology in the operating room, and further improve positive patient outcomes following THA. We hypothesize that including technological assistance in THAs will yield better patient outcomes compared to surgeries performed freehand.
Eligibility Criteria
Inclusion Criteria: * osteoarthritis of the hip requiring primary THA * 40 years of age or older * BMI \<40 kg/m2 * able to provide informed consent, able and willing to do study assessments and follow instructions Exclusion Criteria: * prior surgery on the indicated hip with insertion of hardware * prior surgery on the lower spine with insertion of hardware * hip and/or spinal fixed deformities or inflammatory/ossification processes of the spine (e.g. DISH, ankylosing spondylolisthesis) * limitations to range of motion of the contralateral hip
Contact & Investigator
Brent Lanting
PRINCIPAL INVESTIGATOR
London Health Sciences Centre/Lawson
Frequently Asked Questions
Who can join the NCT05221554 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Total Hip Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05221554 currently recruiting?
Yes, NCT05221554 is actively recruiting participants. Contact the research team at Brent.Lanting@lhsc.on.ca for enrollment information.
Where is the NCT05221554 trial being conducted?
This trial is being conducted at London, Canada.
Who is sponsoring the NCT05221554 clinical trial?
NCT05221554 is sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. The principal investigator is Brent Lanting at London Health Sciences Centre/Lawson. The trial plans to enroll 80 participants.